Observational studyJapanese journal of ophthalmology2026

Real-world six-month outcomes after switching from aflibercept 2 mg to aflibercept 8 mg for neovascular age-related macular degeneration.

Hiroya Kindo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.